Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

FUSN Fusion Pharmaceuticals Inc

21,55

0,00 (0,00%)

22 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Fusion Pharmaceuticals (NASDAQ:FUSN)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Fusion Pharmaceuticals Charts.

Fusion Pharmaceuticals (NASDAQ:FUSN)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Fusion Pharmaceuticals Charts.

News Fusion Pharmaceuticals Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 17 Juni 2024 (5 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Montag 10 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 4 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Fusion Pharmaceuticals Inc News-Artikel

DIFV26F27 - 10/2026

XMWQEUE1CGBPINAV

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen